Fig. 2: Outcomes with lenalidomide retreatment.
From: Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
A Progression free survival in next lenalidomide-containing line of therapy. B Overall survival from next lenalidomide containing line of therapy.
